11.53
price down icon0.86%   -0.10
after-market Dopo l'orario di chiusura: 11.76 0.23 +1.99%
loading
Precedente Chiudi:
$11.63
Aprire:
$11.55
Volume 24 ore:
721.52K
Relative Volume:
0.83
Capitalizzazione di mercato:
$881.46M
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-3.9896
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
-4.63%
1M Prestazione:
-3.68%
6M Prestazione:
-42.15%
1 anno Prestazione:
-45.33%
Intervallo 1D:
Value
$11.26
$11.72
Intervallo di 1 settimana:
Value
$11.12
$12.31
Portata 52W:
Value
$8.18
$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Name
Nome
Nurix Therapeutics Inc
Name
Telefono
(415) 660-5320
Name
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Name
Dipendente
286
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-09
Name
Ultimi documenti SEC
Name
NRIX's Discussions on Twitter

Confronta NRIX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NRIX
Nurix Therapeutics Inc
11.53 860.06M 54.55M -193.57M -181.86M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-17 Iniziato Leerink Partners Market Perform
2024-12-10 Iniziato BTIG Research Buy
2024-12-06 Iniziato BMO Capital Markets Outperform
2024-10-24 Iniziato UBS Buy
2024-10-11 Iniziato Jefferies Buy
2024-09-06 Ripresa Robert W. Baird Outperform
2024-07-31 Iniziato Truist Buy
2023-06-26 Ripresa Oppenheimer Outperform
2023-03-09 Iniziato Barclays Overweight
2023-02-28 Iniziato Oppenheimer Outperform
2022-10-11 Iniziato Morgan Stanley Equal-Weight
2022-05-31 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-02-10 Iniziato Wells Fargo Equal Weight
2021-12-29 Iniziato H.C. Wainwright Buy
2021-10-14 Iniziato SVB Leerink Outperform
2021-06-04 Ripresa Robert W. Baird Outperform
2021-04-30 Ripresa Piper Sandler Overweight
2021-04-30 Iniziato RBC Capital Mkts Outperform
2021-04-14 Iniziato Berenberg Buy
2020-11-19 Iniziato Robert W. Baird Outperform
2020-08-18 Iniziato JP Morgan Overweight
2020-08-18 Iniziato Needham Buy
2020-08-18 Iniziato Piper Sandler Overweight
2020-08-18 Iniziato Stifel Buy
Mostra tutto

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

pulisher
Jul 24, 2025

Massachusetts Financial Services Co. MA Decreases Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight - GlobeNewswire Inc.

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Nurix Therapeutics Inc. stock pricePowerful market insights - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Nurix Therapeutics Inc. a good long term investmentExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Nurix Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Hussman Strategic Advisors Inc. Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Jul 23, 2025
pulisher
Jul 22, 2025

Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 5.4%What's Next? - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Janux Therapeutics Receives Buy Rating from Leerink Partners Amid Strategic Initiatives and Long-Term Growth Potential - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Nurix Therapeutics Inc. stockUnmatched profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Q3 EPS Forecast for Nurix Therapeutics Raised by Analyst - MarketBeat

Jul 19, 2025
pulisher
Jul 18, 2025

Janux Therapeutics (JANX) Soars 2.31% on R&D Day Announcement - AInvest

Jul 18, 2025
pulisher
Jul 17, 2025

Nurix Therapeutics’ SWOT analysis: biotech stock’s pivotal trials and pipeline progress By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Nurix Therapeutics’ SWOT analysis: biotech stock’s pivotal trials and pipeline progress - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

When (NRIX) Moves Investors should Listen - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 15, 2025

Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

NRIX: Morgan Stanley Lowers Price Target for Nurix Therapeutics - GuruFocus

Jul 15, 2025
pulisher
Jul 14, 2025

A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts - Benzinga

Jul 14, 2025
pulisher
Jul 14, 2025

Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $34.00 at HC Wainwright - MarketBeat

Jul 14, 2025
pulisher
Jul 14, 2025

H.C. Wainwright Adjusts Price Target for Nurix Therapeutics (NRI - GuruFocus

Jul 14, 2025
pulisher
Jul 14, 2025

Navigating Nurix Therapeutics' Early-Stage Biotech Landscape: A Strategic SWOT Analysis - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Broker Revenue Forecasts For Nurix Therapeutics, Inc. (NASDAQ:NRIX) Are Surging Higher - simplywall.st

Jul 14, 2025
pulisher
Jul 13, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat

Jul 13, 2025
pulisher
Jul 13, 2025

Nurix Therapeutics (NASDAQ:NRIX) Price Target Cut to $30.00 by Analysts at Oppenheimer - MarketBeat

Jul 13, 2025
pulisher
Jul 13, 2025

Nurix Therapeutics (NASDAQ:NRIX) Issues Earnings Results - MarketBeat

Jul 13, 2025
pulisher
Jul 13, 2025

Nurix Therapeutics: The BTK Disruptor With Undervalued Upside Potential - AInvest

Jul 13, 2025
pulisher
Jul 13, 2025

Nurix Therapeutics Could Disrupt BTK Therapy And Reward Investors (NASDAQ:NRIX) - Seeking Alpha

Jul 13, 2025
pulisher
Jul 13, 2025

UBS Group Lowers Nurix Therapeutics (NASDAQ:NRIX) Price Target to $26.00 - MarketBeat

Jul 13, 2025
pulisher
Jul 12, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Up 7.8% After Earnings Beat - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

Top 3 Trending Stocks: Ultragenyx Pharmaceutical, Rhythm Pharmaceuticals, and Nurix Therapeutics - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Stifel Nicolaus Keeps Their Buy Rating on Nurix Therapeutics (NRIX) - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Piper Sandler Keeps Their Buy Rating on Nurix Therapeutics (NRIX) - The Globe and Mail

Jul 11, 2025
pulisher
Jul 10, 2025

Nurix Therapeutics (NRIX) Stock Target Price Lowered by UBS Anal - GuruFocus

Jul 10, 2025
pulisher
Jul 10, 2025

Mixed Moves In Health And Biotech Funds - Finimize

Jul 10, 2025

Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):